Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

References for PMC Articles for PubMed (Select 18657663)

1.

Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.

Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML; MADIT-II Investigators.

J Am Coll Cardiol. 2008 Jan 22;51(3):288-96. doi: 10.1016/j.jacc.2007.08.058.

2.

Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death.

Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA.

JAMA. 2007 Oct 3;298(13):1517-24.

PMID:
17911496
3.

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Circulation. 2007 Feb 6;115(5):e69-171. Epub 2006 Dec 28. No abstract available. Erratum in: Circulation. 2007 Feb 6;115(5):e172. Circulation. 2010 Jul 6;122(1):e9. Kissela, Bret [corrected to Kissela, Brett].

4.

Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.

Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M.

Circulation. 2007 Jan 16;115(2):204-12. Epub 2006 Dec 26.

5.

Chronic inotropic therapy in end-stage heart failure.

Hauptman PJ, Mikolajczak P, George A, Mohr CJ, Hoover R, Swindle J, Schnitzler MA.

Am Heart J. 2006 Dec;152(6):1096.e1-8.

6.
7.

Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electrophysiology Organizations (COPE).

Carlson MD, Wilkoff BL, Maisel WH, Carlson MD, Ellenbogen KA, Saxon LA, Prystowsky EN, Alpert JS, Cain ME, Ching EA, Curtis AB, Davies DW, Hammill SC, Hauser RG, Lampert R, Zipes DP; American College of Cardiology Foundation; American Heart Association; International Coalition of Pacing and Electrophysiology Organizations.

Heart Rhythm. 2006 Oct;3(10):1250-73. No abstract available.

PMID:
17018366
8.

Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure.

Stevenson LW, Desai AS.

J Card Fail. 2006 Aug;12(6):407-12. Review.

PMID:
16911905
9.

Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH; SCD-HeFT Investigators.

Circulation. 2006 Jul 11;114(2):135-42. Epub 2006 Jul 3.

10.

Palliation in heart failure: when less and more are more.

Hauptman PJ.

Am J Hosp Palliat Care. 2006 Mar-Apr;23(2):150-2. Review. No abstract available.

PMID:
16572753
11.

The Seattle Heart Failure Model: prediction of survival in heart failure.

Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M.

Circulation. 2006 Mar 21;113(11):1424-33. Epub 2006 Mar 13.

12.

HFSA 2006 Comprehensive Heart Failure Practice Guideline.

Heart Failure Society Of America.

J Card Fail. 2006 Feb;12(1):e1-2.

PMID:
16500560
13.

Cost-effectiveness of implantable cardioverter-defibrillators.

Sanders GD, Hlatky MA, Owens DK.

N Engl J Med. 2005 Oct 6;353(14):1471-80.

14.

Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990 to 2000.

Brown DW, Haldeman GA, Croft JB, Giles WH, Mensah GA.

Am Heart J. 2005 Sep;150(3):448-54.

PMID:
16169322
15.

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.

Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society.

Circulation. 2005 Sep 20;112(12):e154-235. Epub 2005 Sep 13. No abstract available.

16.
17.

Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.

Sackner-Bernstein JD, Skopicki HA, Aaronson KD.

Circulation. 2005 Mar 29;111(12):1487-91. Epub 2005 Mar 21. Erratum in: Circulation. 2005 May 3;111(17):2274.

18.

The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators.

N Engl J Med. 2005 Apr 14;352(15):1539-49. Epub 2005 Mar 7.

19.

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis.

Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ; ADHERE Scientific Advisory Committee, Study Group, and Investigators.

JAMA. 2005 Feb 2;293(5):572-80.

PMID:
15687312
20.

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators.

N Engl J Med. 2005 Jan 20;352(3):225-37. Erratum in: N Engl J Med. 2005 May 19;352(20):2146.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk